Standard Medication for HER-2 Breast Cancer Remained Top Rx
The approval of a new medication represents new options for patients. But the new option isn't always the best option. When it comes to treating HER-2 positive breast cancer, the standard medication still appears to beat the newer option.
FDA Expands Use of Breast Cancer Rx
For the first time in its history, the US Food and Drug Administration has approved a medication for the pre-surgical (neoadjuvant) treatment of early-stage (I, II) breast cancer.
Accelerated FDA Review For HER2-Positive Drug
HER2-positive breast cancer is one of the most aggressive forms of the disease. A new treatment option may soon be available to help battle this vicious cancer.